Semaglutide can still produce significant weight loss in this population, but the timeline may be extended, and the magnitude may be somewhat reduced compared to premenopausal women
WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6
While patients require a medical history of MASH, liver biopsy might not be absolutely required for medication approval and may be supplemented by liver fibrosis imaging (transient elastography [FibroScan] or magnetic resonance elastography) and noninvasive fibrosis scoring (fibrosis-4 index)
BSO treatment alone did not significantly decrease cell viability (data not shown) and had no profound effect on the cytotoxicity of AQ or DEAQ ( Figure 2 )
Patients who had used a semaglutide were categorized into cohorts based on when they discontinued the semaglutide before surgery: 30 days prior to surgery , n=482 patients 14 days prior to surgery, n=591 patients 7 days prior to surgery, n=680 patients 5 days prior to surgery, n=758 patients 3 days prior to surgery, n=777 patients 1 day prior to surgery, n=706 patients Did not stop a semaglutide prior to surgery, n=170 patients These patients were compared to a control group of 206,005 patients with no history of semaglutide use
